A nurse is assessing a patient who received the first cycle of FOLFOX chemotherapy (5-fluorouracil, leucovorin, and oxaliplatin) 10 days ago. Which assessment finding would be the priority concern requiring immediate intervention?

Severe neutropenia (ANC 480/mm³) is a critical finding post-chemotherapy nadir, requiring immediate intervention to prevent life-threatening infections. Other options represent common side effects (fever, neuropathy, nausea) that are less urgent.

Core Nursing Explanation Key Concept Analysis: This question tests the critical nursing skill of prioritizing patient problems based on the timing and severity of chemotherapy side effects. The patient is 10 days post-FOLFOX, which is a common nadir period for bone marrow suppression. The priority is identifying the most life-threatening complication requiring immediate action.

Answer Rationale: Key Point! Option 4 is correct because it indicates severe neutropenia. An Absolute Neutrophil Count (ANC) of 480/mm³ is classified as Grade 4 neutropenia (Normal ANC > 1,500/mm³). This places the patient at extreme risk for severe, life-threatening infection, which is the leading cause of morbidity and mortality in patients receiving myelosuppressive chemotherapy. This finding requires immediate intervention such as administering colony-stimulating factors, initiating protective isolation, and evaluating for signs of infection.

Distractor Analysis:
• Watch out for confusion! Option 1: A low-grade fever (100.2°F / 37.9°C) in a non-neutropenic patient might be monitored. However, in the context of the severe neutropenia revealed in option 4, this fever becomes a medical emergency (febrile neutropenia). The question asks for the priority concern, and the lab value itself (indicating the high-risk state) is the critical finding that mandates action even before a fever spikes.
• Option 2: Numbness and tingling triggered by cold (cold-induced paresthesia) is a classic, acute neurotoxicity of oxaliplatin. While distressing and requiring patient education (e.g., avoid cold drinks, wear gloves), it is not immediately life-threatening.
• Option 3: Nausea and mild weight loss are expected side effects of chemotherapy (especially from 5-FU) and are managed with antiemetics and nutritional support. They are important but not the highest priority in this scenario.

Related Concepts: The nadir (point of lowest blood cell counts) typically occurs 7-14 days after chemotherapy. Nursing care must focus on infection prevention during this period. The concept of "febrile neutropenia" (single temperature ≥ 100.4°F / 38.0°C or sustained ≥ 100°F / 37.8°C with ANC < 500/mm³) is a true oncology emergency.
Concept Summary • FOLFOX Regimen: 5-Fluorouracil (5-FU, myelosuppression, mucositis), Leucovorin (enhances 5-FU), Oxaliplatin (neuropathy, cold sensitivity). • Nadir Period: Lowest blood counts ~7-14 days post-chemo. Critical for monitoring CBC with differential. • Absolute Neutrophil Count (ANC) Priority: ANC = (Segs + Bands) x WBC. < 500/mm³ = Severe risk. < 100/mm³ = Profound risk. • Oncology Nursing Priorities: A (Airway) B (Breathing) C (Circulation) I (Infection Risk) – Infection risk from neutropenia is often the top priority in stable chemo patients.
Side-by-Side Comparison!

Chemotherapy Side Effect	Typical Onset	Key Nursing Concern & Priority
Myelosuppression (Neutropenia)	Nadir: 7-14 days	HIGHEST PRIORITY. Risk of fatal infection. Monitor for fever, initiate neutropenic precautions.
Neuropathy (Oxaliplatin)	Acute (during infusion) & Chronic (cumulative)	Patient safety (falls, burns), education on cold avoidance. Manage chronic symptoms.
Nausea/Vomiting (5-FU)	Acute (within 24 hrs) & Delayed (days after)	Prevent dehydration, malnutrition. Administer scheduled antiemetics, not just PRN.
Mucositis (5-FU)	5-7 days post-chemo	Pain management, nutritional support, oral care protocol to prevent infection.

Anatomy, Physiology & Pharmacology Points • Bone Marrow Physiology: Chemotherapy targets rapidly dividing cells, affecting the bone marrow's ability to produce neutrophils (fight bacteria), platelets (clotting), and RBCs (oxygen). • Drug Mechanism: 5-FU inhibits DNA/RNA synthesis. Oxaliplatin causes DNA cross-linking. Both damage cancer cells and healthy rapidly dividing cells. • Lab Value Interpretation: WBC of 1,200/mm³ is leukopenia. The critical finding is the derived ANC.
Memory Tips • ANC Danger Zone: Remember "500 is critical." ANC < 500 = Severe neutropenia = High infection risk. • FOLFOX Side Effects: Use the mnemonic "Fever risk (myelosuppression), Ouch cold (neuropathy), Low appetite (nausea)." The F (fever risk) is always the top priority. • Nadir Timing: Think "One to two weeks, watch the peaks" – blood counts hit their lowest point 1-2 weeks after chemo.
High-Frequency NCLEX Topics Prioritizing lab values, especially ANC in oncology, is a classic NCLEX-RN question. The exam tests your ability to recognize abnormal values that indicate an immediate threat to life versus expected side effects. Always ask yourself: "Which finding, if left untreated, could lead to death the fastest?" In this case, overwhelming sepsis from neutropenia.
Watch Out for Question Variations! • Instead of giving the ANC, the question might state: "WBC 1.2 K/µL with 40% neutrophils" – you must calculate the ANC (1,200 x 0.40 = 480). • The scenario could shift to: "Which patient teaching is most urgent for a patient starting FOLFOX?" The answer would focus on reporting a fever immediately, not avoiding cold drinks. • The question might combine findings: "Fever of 101.5°F AND numbness in fingers" – the fever in a chemo patient still takes priority over neuropathy.

Nursing Clinical Practice Guide Clinical Scenario: You are the nurse on an oncology floor. Mr. Johnson, 58, is here for a follow-up visit 10 days after his first FOLFOX infusion for colon cancer. He mentions feeling more tired than usual. Your routine lab draw comes back with the critical values listed in option 4.

Nursing Intervention Strategy: 1. Immediate Assessment & Communication: Verify the lab results. Assess the patient for any subtle signs of infection (e.g., subtle fever, chills, cough, sore throat, redness at any site). Immediately notify the oncologist or advanced practice provider of the ANC result. This is not a "wait-and-see" situation. 2. Initiate Protective Interventions: Place the patient on neutropenic precautions. This includes: • Private room if in the hospital. • Meticulous hand hygiene for everyone entering the room. • No fresh flowers or potted plants (source of fungi). • Screening visitors for illness. • Instructing the patient to avoid crowds and sick contacts at home. 3. Patient and Family Education: Provide clear, urgent education: • "You must check your temperature twice daily." • "If your temperature is 100.4°F (38.0°C) or higher one time, or 100°F (37.8°C) or higher for over an hour, you must go to the Emergency Department immediately. Do not wait." • Teach signs of infection: fever, chills, cough, burning with urination, redness/swelling. • Reinforce good personal hygiene, especially oral care to prevent mucositis-related infections. 4. Medical Management Collaboration: Anticipate and prepare for orders such as: • Administration of a granulocyte colony-stimulating factor (G-CSF) like filgrastim to stimulate neutrophil production. • Blood cultures and broad-spectrum antibiotics if fever is present.

Patient Safety and Precautions: • Key Point! Never administer a live vaccine (e.g., MMR, varicella) to a patient or their household contacts during this period. • Avoid rectal procedures (suppositories, temperatures) due to high risk of mucosal injury and bacteremia. • Monitor for other sequelae of myelosuppression: anemia (fatigue, pallor) and thrombocytopenia (bruising, bleeding).
Nursing Procedure & Medication Flow Procedure: Managing a Neutropenic Patient 1. Assess: Vital signs (especially temperature), skin/mucous membranes, lung sounds, subjective complaints. 2. Diagnose: Risk for infection, risk for septic shock. 3. Plan: Implement neutropenic precautions, educate on fever action plan, administer ordered growth factors. 4. Implement: Carry out precautions, give medications, document education provided. 5. Evaluate: Monitor for signs of infection, repeat CBC to track ANC recovery.
Medication: Filgrastim (G-CSF) Administration • Action: Stimulates bone marrow to produce neutrophils. • Route: Subcutaneous injection. • Nursing Considerations: Teach self-injection technique for home use. Monitor for bone pain (common side effect), which can be managed with acetaminophen. Do not give within 24 hours before or after chemotherapy.
A Word from Your Senior Nurse "In oncology nursing, we walk a fine line between treating the cancer and protecting the patient from the treatment's dangers. That ANC number isn't just a lab value—it's a direct measure of your patient's defense system. Seeing an ANC of 480 should set off the same internal alarm as seeing a dangerously low blood pressure. Your vigilance in monitoring, educating, and acting swiftly on these counts is what prevents a routine chemotherapy cycle from turning into a life-threatening crisis. On the NCLEX and at the bedside, remember: Infection risk trumps almost everything else in a neutropenic patient."